It is planned to repeat the current study in the future and this may identify shifting disorder profiles
towards diseases of aging and away from disorders of youth assuming that breed popularity wanes over time.
Not exact matches
Collectively, these avenues are aimed at moving
towards defining the role
of activated microglia in
ageing and neurodegenerative
disease, while considering the impact
of systemic infections on the brain in multiple vulnerable neurodegenerative and neurodevelopmental states.
Giving money to SENS research is a great way to help ensure that more progress occurs in the years ahead, moving down the road
towards therapies capable
of bringing
aging under medical control, preventing
age - related
disease, and greatly extending healthy life.
BrightFocus offers research grants to some
of the best scientists in the U.S. and around the world working
towards cures for Alzheimer's
disease,
age - related macular degeneration (AMD) and glaucoma.
The goal for the near future is to align ever more
of the research community and its funding institutions with this goal, and make real progress
towards bringing an end to the pain, suffering, and
disease of aging.
Understanding the genetic basis
of human
age - related
diseases, as well as normal
aging, such as cardiovascular changes,
age - related neurodegenerative
disease, autoimmune
disease, and diabetes constitutes an important step
towards unraveling
disease pathogenesis and risk prediction.
Replenish your vitality, vanquish your pain, experience boundless energy, transform your body, regain your ideal body weight, optimize your hormones, strengthen your bones, regenerate your joints, uplift your moods, rev up your sex life, reverse the effects
of aging, prevent the most common
diseases related to
aging and change your lifestyle
towards a life better than you can imagine.
Patients had to fulfil the following criteria: a diagnosis
of schizophrenia, schizoaffective psychosis, or delusional disorder according to criteria from the Diagnostic and Statistical Manual
of Mental Disorders, 3rd edition, revised11; no evidence
of organic brain
disease; substance abuse not identified as the primary problem;
age between 18 and 65 years; presence
of persistent hallucinations or delusions, or both, for a minimum
of 6 months and at least 1 month
of stabilisation if they had experienced an exacerbation during this period; stable medication; no psychological or family intervention; their responsible medical officer had given permission for them to enter the study; no serious threat
of violence
towards the assessors; and they had given informed consent to participate.